Understanding how tumor DNA in the blood can improve cancer treatment.
Translating the tumor regulome from cell-free DNA for precision oncology
This study is looking at how bits of DNA from tumors in your blood can help doctors find the best treatment just for you, making cancer care more personal and effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10818290 on NIH RePORTER |
What this research studies
This research investigates the use of cell-free DNA from blood samples to better understand tumors and personalize cancer treatment. By analyzing the genetic material shed by tumors into the bloodstream, the study aims to identify specific mutations and characteristics that can guide tailored therapies for individual patients. The approach focuses on translating complex tumor biology into actionable insights for precision oncology, potentially leading to more effective treatment strategies. Patients may have their blood tested to help determine the best course of action for their cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with cancer who are seeking personalized treatment options.
Not a fit: Patients with benign tumors or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual tumor profiles.
How similar studies have performed: Other research has shown promising results using similar approaches to analyze cell-free DNA for cancer treatment, indicating potential for success in this area.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Ha, Gavin — Fred Hutchinson Cancer Center
- Study coordinator: Ha, Gavin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.